Molfino, Nestor A.
Turcatel, Gianluca
Riskin, Daniel
Funding for this research was provided by:
Amgen
Article History
Received: 4 October 2023
Accepted: 15 November 2023
First Online: 19 December 2023
Declarations
:
: NA Molfino and G Turcatel are employees and stockholders of Amgen Inc. D Riskin is the Founder and Chief Executive Officer of Verantos Inc.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.